pulmonary mucormycosis; massive disease due to chronic glomerulonephritis a year earlier haemoptysis; diabetes mellitus; renal transplant recipi-and he had received a live related renal transplant ent; bronchial biopsy from his father 6 months ago. In the second week after transplantation he had acute rejection from which he completely recovered following therapy with pulse methylprednisolone. He was doing well until 1 month
Introduction
before this admission when he had presented with multiple superficial abscesses and altered sensorium. Mucormycosis is a devastating fungal infection which He was diagnosed to have post-transplant diabetes usually occurs in patients with diabetic ketoacidosis, mellitus with ketoacidosis, septicaemia and oesophachronic renal failure, haematological malignancies, or geal candidiasis. He improved with antibiotics, insulin, solid-organ transplant recipients [1] . The four main and ketoconazole. He was maintained on cyclosporin clinical presentations recognized are the rhinocerebral, 4 mg/kg and prednisolone 15 mg daily. pulmonary, gastrointestinal, and disseminated forms.
On admission he was afebrile but had moderate In renal transplant recipients the most common form pallor, a pulse rate of 96/min and BP of 120/80 mmHg. is rhinocerebral, while lung involvement may be seen Chest examination revealed evidence of a consolidation in 10% of patients [2] . Pulmonary mucormycosis may with crepitations over the left infraclavicular area. present as an unresolving pneumonia, multiple nodules, Other systems were normal. or a cavitating abscess, and is associated with an Investigations revealed a haemoglobin of 8.0 g/dl, overall 80% mortality [3, 4] . A deadly combination is total white cell 7×109/l and ESR of 41 mm in 1st the presence of diabetes mellitus and involvement of hour. Serum biochemistry showed urea 7 mmol/l, crealarge airways [5, 6 ] , since in such cases it may result in tinine 150 mmol/l, uric acid 520 mmol/l, cholesterol fatal haemoptysis [7-10].
4.25 mmol/l. Blood sugar levels ranged from 6.3 This report describes the occurrence of fatal massive to13 mmol/l. Although the liver function tests were haemoptysis in a renal transplant recipient who had normal hepatitis B surface antigen was positive. Chest endobronchial and pulmonary mucormycosis follow-X-ray showed a thick-walled cavity in the upper zone ing the development of post-transplant diabetes mel-of the left lung ( Figure 1 ). Sputum was negative for litus and diabetic ketoacidosis.
acid-fast bacilli on three occasions. Even though the Mantoux test was negative he was put empirically on antitubercular treatment in view of Case report the history of haemoptysis, chest X-ray evidence of a cavity, and a wide prevalence of tuberculosis in the A 25-year-old male renal allograft recipient presented area. However, there was no improvement over next to the Emergency department with recurrent bouts of few days. haemoptysis for 10 days before admission. He had had Bronchoscopy revealed that the left upper lobe bronfour such bouts, each time bringing up about chial mucosa was inflamed and purulent secretions 50-100 ml of blood, while in between he had cough were seen in the apicoposterior bronchus. Bronchial with streaky haemoptysis. There was no history of biopsy included fragments of necrotic tissue and accompanying fever or chest pain.
inflammatory exudate in which broad aseptate hyphae He had been diagnosed to have end-stage renal with right-angled branching characteristic of mucor- withdrawal of immunosuppression has been helpful in treating infections [12] .
Diabetes mellitus with ketoacidosis, which our patient developed in the post-transplant period, has been known to be the most common predisposing factor for mucormycosis. Although phagocytic and microbicidal defects are well known in diabetes mellitus, it is the acidosis which plays an important role in development of fungal infections. With the fall in the pH of blood, there is increased release of iron from transferrin and enhanced hyphal growth [1] .
The combination of pulmonary mucormycosis and diabetes mellitus has been recognized as a well-defined clinical disorder of the bronchus and pulmonary vessels that if unrecognized may result in serious complications including atelectasis, abscess formation, and haemorrhage [5] . Of 11 patients with endobronchial disease reviewed by Bigby et al. [3] , nine were diabetic.
Pulmonary mucormycosis presents with cough, fever, pleuritic chest pain or haemoptysis and chest examination may demonstrate rales with evidence of consolidation and pleural friction rub. The radiological findings may be non-specific and include multiple lung nodules, lobar or wedge-shaped infiltrates, cavitating lung abscesses or pleural effusion [3, 13] . The 'aircrescent sign' has been recently recognized as a rare manifestation of both aspergillosis and mucormycosis [8, 13] .
Sputum in patients with pulmonary mucormycosis may be white, yellow, blood-tinged, or grossly bloody. Massive haemoptysis is also described in these patients, and rarely may prove fatal, as seen in our patient and mentioned in isolated case reports earlier [6-9]. In a recent review of 255 patients with pulmonary mucormycosis reported in literature, Tedder et al. docu- 19 (13%) of the 146 patients who had died. [4] . Because of the angioinvasive tendency of the Mucorales, lung 3 days and it was decided to carry out lobectomy. infection leads to the invasion of the pulmonary vessels However, before this could be undertaken, he had a with consequent thrombosis, infarction, and necrosis massive haemoptysis, bringing up around a litre of of the parenchyma. Rupture of vessel into diseased blood; this was followed by cardiorespiratory arrest bronchi leads to massive haemorhage in the large from which he could not be revived.
airways, causing asphyxiation. Diagnosis of pulmonary mucormycosis is rarely made antemortem because of the acute nature of this Discussion illness, lack of awareness of the condition, and the need for tissue to establish the diagnosis. Sputum culture is usually negative but a positive culture is Mucormycosis is caused by ubiquitous saprophytic fungi belonging to the order Mucorales and genera highly suggestive of infection [3] . Definite diagnosis requires histological demonstration of tissue invasion Rhizopus, Absidia, and Mucor [1] . Production of spores which become airborne leads to the primary with characteristic broad aseptate hyphae with rightangled branching. Bronchoscopic examination with inoculation of the respiratory tract in man [3] .
In solid-organ-transplant recipients, immuno-bronchoalveolar lavage has been recently advocated as a useful, safe, and less invasive technique [14] . suppressive therapy is a major predisposing factor for mucormycosis [2] . Corticosteroids affect the immune While amphotericin B is the mainstay of therapy in pulmonary mucormycosis, patients with endobronchial response in many ways [6, 11] . They are also known to activate latent infection, enhance spore germination, disease may benefit from early and aggressive surgical resection of the involved lung tissue. As reported and greatly reduce the lethal dose of the organism [1] . Increased immunosuppression for treatment of rejec-recently by Tedder et al. [4] , mortality was 65% for patients with isolated lung involvement, 96% for those tion is also associated with increased incidence of fungal infections and in many cases reduction or with disseminated disease, and 80% overall. However K. L. Gupta et al. 3260
5. Brown RB, Johnson JH, Kessinger JM, Sealy WC. mortality in patients treated surgically was 11%, which Bronchovascular mucormycosis in the diabetic: an urgent suris very low compared to 68% in those treated medically. gical problem. Ann Thorac Surgery 1992; 53: [854] [855] In conclusion, it is important to recognize the pre- 
